When we think of multinational corporations (MNCs), names like Google, Apple, or Nestlé often come to mind. But India, known for its strong business culture, has also created successful global companies, started in India, grown in India, and now operates globally.
These MNCs founded in India are not just surviving globally; they are leading, innovating, and influencing change on a massive scale. From technology and car manufacturing to medicines and banking, Indian companies are changing how the world works.
This article highlights the top Indian-founded MNCs that have made a massive impact worldwide while staying true to their Indian roots.
List of Top MNCs Founded in India
India is home to some of the world’s most influential multinational corporations that started from scratch and grew into global giants. These companies showcase India’s entrepreneurial spirit and its rising influence on the global economic stage. The following is a list of the top 10 multinational companies founded in India and now operating worldwide:
Tata Group is synonymous with Indian pride. A conglomerate with over 100 companies, Tata operates in automobiles (Tata Motors, Jaguar Land Rover), IT (TCS), hospitality (Taj Hotels), steel, telecom, chemicals, and more.
TCS is among the top global IT service firms.
Tata Motors owns Jaguar Land Rover, headquartered in the UK.
A legacy-driven empire, Aditya Birla Group is one of the largest conglomerates in India with operations in metals, cement, textiles, carbon black, telecom, and financial services.
Present across North America, Europe, Latin America, Asia, and Africa.
Hindalco, UltraTech Cement, and Aditya Birla Capital are major arms.
Employs over 187,000 people globally.
Infosys
Founders
N.R. Narayana Murthy & Team
Founded
1981
Headquarters
Bengaluru, Karnataka
Global Presence
50+ countries
Annual Revenue
19.3 billion U.S. dollars
Infosys is often hailed as the flagbearer of India’s IT revolution. It is among the most prominent Indian IT multinational companies.Starting in a small room in Pune with just seven engineers, Infosys rapidly transformed into a global powerhouse, providing cutting-edge technology solutions, IT consulting, and business process outsourcing to Fortune 500 companies worldwide.
Offers services in cloud computing, AI, machine learning, blockchain, and digital transformation.
Employs over 300,000 skilled professionals globally.
Serves clients across banking, retail, manufacturing, and healthcare sectors.
Pioneer in ethical corporate governance and sustainability practices.
Major presence in North America, Europe, Australia, and Asia
Wipro is a stellar example of business transformation. Originally launched as a manufacturer of vegetable oil in 1945, it operated under the name “Western India Palm Refined Oils.” Over the decades, Wipro evolved into a global IT solutions and consulting powerhouse, thanks to the visionary leadership of Azim Premji, who redirected the company toward technology in the 1980s.
Provides cloud infrastructure, cybersecurity, digital transformation, and consulting services.
Acquired UK-based Capco to expand financial services consulting.
Works with several Fortune Global 1000 companies worldwide.
Strong focus on diversity, sustainability, and innovation.
Larsen & Toubro (L&T)
Founders
H.L. Larsen & S.K. Toubro
Founded
1938
Headquarters
Mumbai, Maharashtra
Global Presence
30+ countries
Annual Revenue
INR 2 Lakh Crore (FY 2024)
L&T is India’s largest engineering and infrastructure conglomerate with a diversified global presence. The company operates across key sectors such as construction, heavy engineering, defense, power, IT services, and financial services.
It operates in over 50 countries worldwide
Known for quality, innovation, and sustainability in engineering projects.
HCLTech
Founder
Shiv Nadar
Founded
1976
Headquarters
Noida, Uttar Pradesh
Global Presence
60+ countries
Annual Revenue
$13.3 billion (FY 2024)
HCLTech is a global leader in IT services and digital innovation. It delivers cutting-edge solutions in cloud computing, cybersecurity, AI, and enterprise IT.
It has acquired companies such as Actian and Volvo’s IT arm to expand its capabilities.
Works with several Fortune 500 companies across industries.
Hindustan Unilever Limited (HUL)
Founded
1933 (as Lever Brothers India Limited)
Headquarters
Mumbai, Maharashtra
Global Presence
Operations in 20+ countries through parent Unilever
Annual Revenue
INR 614 billion (FY 2024)
HUL is India’s largest fast-moving consumer goods (FMCG) company, offering a wide range of products in home care, personal care, and food & beverages. While it’s a subsidiary of the global giant Unilever, HUL operates with a high degree of autonomy and is considered an Indian MNC in its own right due to its massive scale, R&D, and export operations out of India.
Manages a portfolio of 50+ iconic brands like Surf Excel, Dove, Lifebuoy, Lux, and Horlicks.
Employs over 10,000 people directly and supports thousands more through its ecosystem.
Strong focus on sustainability, with brands like Love Beauty & Planet and water-saving initiatives.
Products are exported to markets in Southeast Asia, Africa, and the Middle East.
Operates multiple R&D centers and manufacturing units across India.
M&M (Mahindra & Mahindra) is a leading Indian multinational in the automotive and farm equipment sectors. Known for its rugged SUVs and tractors, it has a strong global presence across over 100 countries.
Operates in the US, Europe, Africa, and Southeast Asia.
Subsidiaries include SsangYong (Korea) and Automobili Pininfarina (Italy).
Bharat Forge
Founder
Babasaheb Neelkanth Kalyani
Founded
1961
Headquarters
Pune, Maharashtra
Global Presence
50+ countries
Annual Revenue
INR 89.7 billion (FY 2024)
Bharat Forge is a world leader in precision forging and engineering components. Headquartered in Pune, it is a flagship company of the Kalyani Group and serves diverse sectors including automotive, aerospace, oil & gas, power, and defense.
Partners with global defense and space technology firms.
Known for high-precision manufacturing and innovation.
Dr. Reddy’s Laboratories
Founder
Dr. K. Anji Reddy
Founded
1984
Headquarters
Hyderabad, Telangana
Global Presence
42 countries
Annual Revenue
INR 8,506 Crore
Dr. Reddy’s Laboratories is a major player in the global pharmaceutical industry, known for its generic medicines, active pharmaceutical ingredients (APIs), and biotechnology products.
It operates in the US, Europe, Russia, and emerging markets.
Focuses on affordable healthcare with extensive R&D and manufacturing in India.
Supplies to major hospitals and health systems worldwide.
Tech Mahindra
Founded
1986
Part of
Mahindra Group
Headquarters
Pune, Maharashtra
Global Presence
90+ countries
Annual Revenue
$2.6 billion (FY 2024)
Tech Mahindra is a key player in IT services and digital transformation, offering cutting-edge solutions in AI, cloud, 5G, cybersecurity, and enterprise automation.
Provides software development, cloud solutions, enterprise mobility, and telecom services.
Serves top global telecom players and Fortune 500 clients.
Delivery centers in the US, UK, Philippines, and Germany.
In India, multinational corporations are not just local success stories but global powerhouses reshaping industries, setting innovation benchmarks, and putting India firmly in the world spotlight.
What unites them is not just their Indian origin, but their world-class ambition, ethical foundations, and relentless pursuit of growth through innovation. In an era when India continues to rise as a global economic force, MNCs will remain at the forefront, expanding India’s influence, creating millions of jobs, and building innovations for a better, smarter future.
Multinational corporations (MNCs) are companies that operate in multiple countries beyond their home country, managing production or delivering services on a global scale.
What are some multinational companies (MNCs) founded in India?
Some multinational companies (MNCs) founded in India are:
Tata Group
Aditya Birla Group
Infosys
Wipro
Larsen & Toubro (L&T)
HCLTech
Hindustan Unilever Limited (HUL)
Mahindra & Mahindra
Bharat Forge
Dr. Reddy’s Laboratories
Tech Mahindra
How are the top MNCs in India determined?
The ranking of top MNCs in India is usually based on various factors, including revenue, market share, brand reputation, growth rate, and social impact.
According to media reports, pharmaceutical giant Dr. Reddy’s Laboratories has started a comprehensive downsizing programme with the goal of reducing its personnel costs by over 25%. According to the report, numerous senior officials, including numerous workers who make more than INR 1 crore a year, have been asked to step down. According to a media report, voluntary retirement has been extended to employees in the company’s research and development (R&D) division who are between the ages of 50 and 55. According to the article, a number of high-paid employees from different departments have already been asked to step down.
Move Aligned with Company’s Aim of Improving Operational Efficiencies
This occurs when Dr. Reddy’s Laboratories keeps making strategic decisions to increase operational efficiencies. The pharmaceutical company recently launched a number of new medications and ventured into digital treatments and nutraceuticals (via a joint venture with Nestlé). The business has made significant hiring in recent years to support these new endeavours. The corporation may have to reduce the number of its staff if these new endeavours do not perform as expected. The nutraceuticals arm may experience some downsizing, while the therapeutics branch may be completely shut down. 300–400 individuals might be laid off as a result of this. Interestingly, in Q3 of FY25, the company recorded consolidated employee benefits expenses of INR 1,367 crore. Compared to the INR 1,276 crore in employee benefits expenses recorded in Q3 of FY24, this represented an almost 7% increase.
Layoffs have Become a Common Scenario in 2025
With big companies like Google, Microsoft, and others continuing to reduce their workforces, layoffs in the tech sector are not expected to halt in 2025. Companies are still cutting employees in an effort to simplify operations, save money, and emphasise automation and artificial intelligence, even though these figures are much lower than the major layoffs that occurred between 2022 and 2023. Layoffs.fyi, a website that tracks layoffs in the industry, reports that 93 organisations have laid off nearly 23,500 tech workers so far this year, and the number is still growing. Google and Microsoft are apparently contemplating a new round of layoffs, according to the most recent job reduction reports. According to reports, AI-led restructuring and performance-based terminations are part of the corporations’ goals to increase the effectiveness of their personnel.
In its Platforms and Devices division, which manages important products including Android, Pixel devices, and the Chrome browser, Google, a subsidiary of Alphabet, laid off hundreds of workers. The action comes after the corporation launched a voluntary exit programme in January, indicating that it is working towards a more streamlined and flexible organisational structure. According to reports, Microsoft is also preparing for another round of layoffs that may begin as early as May 2025. Talks are apparently underway to boost the proportion of engineers to non-technical personnel and decrease middle-management positions.
The tsunami of IT layoffs in 2025 is not limited to industry titans; many other businesses in many sectors are also reducing their workforces significantly. The parent company of WordPress, Automattic, announced a 16% layoff that will impact about 270 workers. Likewise, Canva fired 10–12 technical writers in response to the company’s push for AI-generated content.
India’s pharmaceutical industry has come a long way since its early days of producing generic drugs for the world. Today, the country is home to some of the largest and most innovative pharmaceutical companies in the world.
According to the Indian Economic Survey 2021, the domestic market is expected to grow 3x in the next decade. India’s domestic pharmaceutical market stood at US$ 42 billion in 2021 and is likely to reach US$ 65 billion by 2024 and further expand to reach US$ 120-130 billion by 2030.
Indian drug & pharmaceutical exports increased from US$ 16.8 billion to US$ 25.4 billion from 2016-17 to 2022-23. Indian drug & pharmaceutical exports stood at US$ 2,196.32 million in September 2022.
In this article, we will explore the Top 20 Pharmaceutical Companies in India and their contributions to the industry.
Top Pharmaceutical Companies of India – Sun Pharmaceutical Industries Ltd.
It is a leading multinational pharmaceutical company in India. Sun Pharma was established in the year 1983. It was founded by Mr. Dilip Shanghvi,who is also the MD of Sun Pharmaceuticals. Sun Pharmaceutical Industries’ revenue wasINR44,520 cr in 2023. The company started offering products to treat psychiatric ailments. Now, the company also offers formulations in various therapeutic, gastroenterology, and diabetology.
Sun Pharmaceutical Industries is one of the largest pharmaceutical company in India based on overall revenue. It is the fourth largest global specialty generic pharmaceutical company in the world. It also sells Carbamazepine, Etodolac, and Clorazepate as well as anti-cancer, steroids, peptides, sex hormones, and controlled substances. Its subsidiaries include Ranbaxy Laboratories and Sun Petrochemical Pvt. Ltd, Sun Ophthalmic Inc, Alkaloida Chemical Company Zrt, Chattem Chemicals Inc. This pharmacy business sells affordable medicines in over 150 countries across 6 continents.
Top Pharmaceutical Companies of India – Divi’s Laboratories
Divi’s Laboratories Limited is a noteworthy player among the top 20 pharma companies in India. This Indian multinational pharmaceutical company, headquartered in Hyderabad, has made a significant impact on the global pharmaceutical industry. Divi’s Laboratories was founded in 1990. Divi’s Laboratories Ltd. manufactures active pharmaceutical ingredients (APIs) and intermediates. This pharmaceutical company in India is engaged in the manufacture of leading generic compounds, Nutraceutical ingredients, custom synthesis of APIs, and intermediates for global innovator companies. Divi’s Laboratories is one of the largest API companies in the world, with a revenue of INR 8,112.17 cr in 2023, and exporting to more than 95 countries.
3. Dr. Reddy’s Laboratories
Company Name
Dr. Reddy’s Laboratories
Founded
1984
Owner
Dr. Kallam Anji Reddy
Headquarters
Hyderabad
Website
www.drreddys.com
Top Pharmaceutical Companies of India – Dr. Reddy’s
Dr. Reddy’s Laboratories was founded by Anji Reddy in 1984. It is an Indian multinational pharmaceutical company. It is known for manufacturing a wide range of pharmaceuticals in India and overseas. They have over 190 medications, 60 active pharmaceutical ingredients for drug manufacturers, diagnostics kits, critical care, and biotechnology products. It had a revenue of INR 25,725.20 cr in 2023. The notable products of Dr. Reddy’s include Canagliflozin. Ramipril, Ibuprofen, Naproxen, Atorvastatin, Nizatidine, Naproxen Sodium, etc.
4. Cipla Limited
Company Name
Cipla Limited
Founded
1935
Owner
Yusuf Hamied
Headquarters
Mumbai
Website
www.cipla.com
Top Pharmaceutical Companies of India – Cipla
Cipla is an Indian multinational pharmaceutical and biotechnology company, that has its headquarters in Mumbai and was established in 1935 by Khwaja Abdul Hamied. Yusuf Hamied is the Non-Executive Chairman of Cipla. This pharmaceutical company in India focuses on developing medicines to treat respiratory, and cardiovascular diseases, arthritis, diabetes, weight control, depression, and many more.
Cipla had a revenue of INR 23,228.57 cr in 2023 and has more than 22,036 employees. The subsidiaries of Cipla are Invagen Pharmaceuticals. They are the largest manufacturer of antiretroviral drugs.
Emcure Pharmaceuticals is a Pune-based company, which was founded in 1983 by Satish Ramanlal Mehta. It was to address the vision of fulfilling the vast healthcare needs that Emcure Pharmaceuticals was born. Emcure Pharmaceuticals started as a single manufacturing facility in Pune and has witnessed healthy growth throughout the years, now boasting a range of world-class manufacturing facilities spread across API, formulations, and biotechnology. Emcure is now known as a vertically integrated pharmaceutical company with commendable infrastructure, skills, and resources that are not only comparable to the best pharma companies in Pune, India but those that are considered as the best in the world. Manufacturing of APIs, Formulations, and Biotechnology can all be summed up as strengths of Emcure.
Namita Thapar, who is distinguished as one of the judges of Shark Tank India, is the Executive Director of Emcure’s India business.
Founded in the year 1978, Biocon is the most popular pharmaceutical company in India. Biocon Limited manufactures generic active pharmaceuticals. The company is based out of Bengaluru. Products from Biocon Limited are sold around the world on a very huge scale. More than 9000 people are employed at Biocon and the company holds total assets valued at over $824 million.
7. Torrent Pharma
Company Name
Torrent Pharma
Founded
1959
Owner
Sudhir Mehta
Headquarters
Ahmedabad
Website
www.torrentpharma.com
Top Pharmaceutical Companies of India – Torrent Pharmaceuticals
Torrent Pharmaceuticals is a leading Indian multinational pharmaceutical company that specializes in the production of generic drugs and active pharmaceutical ingredients. It is based in Ahmedabad and has a revenue of INR 9,665.29 cr as of 2023. Torrent has manufacturing plants at Dahej, Pithampur, Gujarat, and Madhya Pradesh. Torrent Pharma makes medicinal drugs for the Central Nervous System, gastrointestinal pain management, gastrointestinal diabetology, and anti-infective segments. It is committed to providing high-quality and affordable healthcare solutions to patients across the world.
Top Pharmaceutical Companies of India – Lupin Limited
Lupin is a leading Indian multinational pharmaceutical company based in Mumbai that specializes in the development, production, and marketing of generic and branded drugs. Lupin was established in 1968 by Desh Bandhu Gupta. It is the 12th-largest company by market capitalization and is thus one of the most well-known pharmaceutical manufacturers in India. Lupin had a revenue of INR 16,715.02 cr in 2023. The company is involved in the manufacturing and selling of medicines ranging from pediatrics, cardiovascular, anti-infectives, diabetology, asthma, and anti-tuberculosis.
Lupin Limited has its major markets in the USA (Baltimore, Maryland), India Region Formulations, Europe, Japan, South Africa, Australia, Philippines, Mexico, Latin America, etc. Some of the subsidiaries of Lupin Ltd. are Lupin Pharmaceutical Inc., Kyowa Pharmaceutical Industry Co. Ltd., and many more.
Top Pharmaceutical Companies of India – Zydus Lifesciences
Zydus Lifesciences Limited (formerly Cadila Healthcare) was founded in 1952 by Ramabhai Patel. It is also known as Zydus Cadila. It is an Indian pharmaceutical company headquartered in Ahmedabad. It is one of the largest pharma companies in India and had a revenue of INR 17,424 cr in 2023.
Zydus Lifesciences Limited is also known for excellent diagnostics, along with being a manufacturer of herbal, skincare, and other OTC products. The company also produces generics for hepatitis C treatment, based on the voluntary license agreement with Gilead. Cadila makes API at three sites in India which are Ankleshwar plant, the Vadodara plant, and Patalganga.
P. V. Ramaprasad Reddy and Mr. K. Nityananda Reddy
Headquarters
Hyderabad
Website
www.aurobindo.com
Top Pharmaceutical Companies of India – Aurobindo Pharma Limited
Aurobindo Pharma Limited was established in 1986. It sells over 300 products in over 125 countries and its key segment is APIS, as 35% of the total revenue is generated from API. It is the second-biggest pharmaceutical company in India and had a revenue of INR 25,145.97 cr in 2023. Aurobindo Pharma Limited is engaged in the manufacturing and selling of medicines in the fields of neurosciences, cardiovascular, Antiretrovirals, anti-diabetics, gastroenterology, cephalosporins, etc.
11. Intas Pharmaceuticals Limited
Company Name
Intas Pharmaceuticals Limited
Founded
1986
Owner
Hasmukh Chudgar
Headquarters
Ahmedabad
Website
www.intaspharma.com
Top Pharmaceutical Companies of India – Intas Pharmaceuticals
Intas Pharmaceuticals Limited, based in Ahmedabad was founded in 1984 and had a revenue of $2.2 Billion in 2022. It has 13 commercialized biosimilars including Docetaxel and Paclitaxel. This pharma company in India has its R&D department in the field of chronic disease of oncology (cancer), rheumatology, auto-immune, nephrology, ophthalmology, and plasma-derived product-based therapies.
This pharmaceutical company has its headquarters in Ahmedabad and is one of the leading biosimilar product manufacturers in Asia. Intas has 14 formulation manufacturing facilities, of which seven are located in India and the rest in the UK and Mexico. It is the seventh-largest company in India, and the company saw an increase in revenue by 29.84% in 2017.
12. Glenmark Pharma Limited
Company Name
Glenmark Pharma Limited
Founded
1977
Owner
Glenn Saldanha
Headquarters
Mumbai
Website
Glenmarkpharma.com
Top Pharmaceutical Companies of India – Glenmark Pharma Limited
Glenmark Pharma Limited is a pharma company headquartered in Mumbai, India that was founded in 1977 by Gracias Saldanha. This pharmaceutical company has drug discovery that plays an important role in the field of therapeutic areas of dermatology, respiratory, and oncology. It is the eighth largest pharma company and had a revenue of INR 13,306.90 cr in 2023. The company also focused on new biosimilar drugs and in the fields of cancer, dermatology, and respiratory diseases, by collaborating with major pharma companies.
Top Pharmaceutical Companies of India – Innovexia Life Sciences
Innovexia Life Sciences Pvt. Ltd. is one of the best pharmaceutical companies in India. It is involved in the manufacturing as well as the trading of various antacid medications, anti-allergic tablets, capsules, etc. It is also known as a top PCD Pharma Franchise company, that keeps investing and equipping itself with state-of-the-art facilities for high-quality medicines.
14. Biophar Lifesciences Pvt. Ltd.
Company Name
Biophar Lifesciences Pvt. Ltd.
Founded
2010
Owner
Gulshan Rawat
Headquarters
Chandigarh
Website
Biopharlifesciences.co.in
Top Pharmaceutical Companies of India – Biophar Lifesciences Pvt. Ltd.
Biophar is a prominent player among the top 20 pharma companies in India, based in Chandigarh it deals in the PCD Pharma Franchise Business and manufacturing. The quality and reasonably priced formulations make the company one of the most reliable companies in India. Biophar has been expanding its client base by reaching every corner of the nation and adding more distributors. It is the constant endeavor that the company takes, which helps its business spread to other parts and create new networks.
15. Mankind Pharma Limited
Company Name
Mankind Pharma Limited
Founded
1995
Owner
R. C. Juneja and Rajeev Juneja
Headquarters
New Delhi
Website
www.mankindpharma.com
Top Pharmaceutical Companies of India – Mankind Pharma Limited
Mankind Pharma Limited is a pharma company in India that has its headquarters in New Delhi. It was founded in 1995 and helps in the production and sale of a wide range of products, including Antibiotics, Antifungals, NSAIDs, Gastrointestinal, Anthelmintic, Cardiovascular, Dermal, Erectile Dysfunction, and several other categories. The company had a revenue of approximately INR 8,878 cr in 2023 and is one of the top Indian pharma company.
16. Piramal Enterprises Limited
Company Name
Piramal Enterprises Limited
Founded
1984
Owner
Ajay Piramal
Headquarters
Mumbai
Website
www.piramal.com
Top Pharmaceutical Companies of India – Piramal Enterprises Ltd.
Piramal Enterprises Limited is one of the popular companies for Pharmaceuticals in India. It was founded in 1984 and was acquired by Ajay Piramal in the early 1980s. The global business conglomerate deals with healthcare, life sciences, drug discovery, healthcare, etc. The company further deals with pharma, critical care, consumer products, phytomedicine, and imaging. Piramal Enterprises Limited is based on total revenue of INR 9,086.74 cr in 2023.
17. Laurus Labs Ltd.
Company Name
Laurus Labs Ltd.
Founded
2005
Owner
Dr. Satyanarayana Chava
Headquarters
Hyderabad
Website
www.lauruslabs.com
Top Pharmaceutical Companies of India – Laurus Labs Ltd.
Laurus Labs, a leading research and development-driven Indian pharma and biotech company, is a notable player in the top 20 pharma companies in India and had a revenue of INR 6,046.55 cr in 2023. Laurus Labs is headquartered in Hyderabad and has its manufacturing plants located at Visakhapatnam, Hyderabad, and Bangalore. The company mainly focuses on active pharma ingredients, finished dosage forms, synthesis, and biotechnology. Laurus Labs leads in generic active pharmaceutical ingredients (‘APIs’) certain high-growth therapeutic areas of antiretrovirals (‘ARVs’), Hepatitis C, and Oncology.
Laurus Labs is a 4000-employee organization all of whom are always looking out to expand the horizons of Chemistry to develop new cures and new methods to cure people along with making a considerable profit. The employees of Laurus Labs Ltd. include pharmaceutical and biotechnology industry veterans, research scientists, manufacturing and management professionals, and more.
18. Abbott India Ltd.
Company Name
Abbott India Ltd.
Founded
1944
Owner
Abbott Laboratories
Headquarters
Mumbai
Website
www.abbott.co.in
Top Pharmaceutical Companies of India – Abbott India Ltd.
Founded in 1944, Abbott is a subsidiary of Abbott Laboratories of USA, established back in 1910 and always dedicated to helping people live healthier lives. Abbott India is responsible for manufacturing a diverse range of nutritional products, diagnostic tools, branded generic pharmaceuticals, diabetes, vascular devices, and more.
Abbott’s products can be categorized into a wide range of therapeutic categories like women’s health, gastroenterology, cardiology, metabolic disorders, and primary care.
Headquartered in Mumbai, Abbott is one of the oldest pharmaceutical companies in India and among the largest MNC pharma companies.
19. Alkem Laboratories
Company Name
Alkem Laboratories
Founded
1973
Owner
Samprada Singh
Headquarters
Mumbai
Website
www.alkemlabs.com
Top Pharmaceutical Companies of India – Alkem Laboratories
Alkem or Alkem Laboratories Ltd. is one of the Indian multinational pharma companies from Mumbai that produces and sells pharmaceutical generics, formulations, and nutraceuticals in India and around the world. It had a revenue of INR 11,815.34 cr in 2023.
Alkem Laboratories has successfully set up 21 manufacturing plants, as of September 2021, out of which 19 plants are in India and 2 of Alkem’s plants are in the US. Alkem boasts of around 5 decades worth of popularity. Taxim from Alkem emerged as the first anti-infective drug to cross the 1,000 million mark of domestic sales in 2006.
20. Alembic Pharmaceuticals
Company Name
Alembic Pharmaceuticals
Founded
1907
Owner
Chirayu Amin
Headquarters
Vadodara
Website
Alembicpharmaceuticals.com
Top Pharmaceutical Companies of India – Alembic Pharmaceuticals
Alembic Pharmaceuticals was founded in 1907 in Vadodara, Gujarat. The company is involved in manufacturing pharmaceutical products, pharmaceutical substances, and intermediaries and has set up its manufacturing plants in Panelav and Karakhadi, Gujarat, and Sikkim.
The company initially started as Alembic Chemical Works in 1907, when the company began manufacturing tincture and alcohol in its unit at Vadodara. With its name in the Forbes’ 2016 list of ‘India’s Super 50 Companies 2016’, Alembic Pharmaceuticals is one of the most popular pharmaceutical brands in India.
Conclusion
India has a rapidly growing pharmaceutical industry and is becoming a major player in the global market. The top pharmaceutical companies in India, including Torrent Pharmaceuticals, Lupin, and Zydus Lifesciences Limited, have made significant contributions to the industry through their innovative products and commitment to high-quality healthcare solutions. These companies have a global presence and are expanding their reach to new markets, with a focus on affordable healthcare solutions for patients worldwide. With India’s growing expertise in the field of pharmaceuticals, the industry is set to witness significant growth in the years to come.
FAQs
What are the top 20 pharmaceuticals in India?
Here is the list of the top 20 pharmaceutical companies in India:
Sun Pharmaceutical Industries
Divi’s Laboratories
Dr. Reddy’s Laboratories
Cipla Limited
Emcure Pharmaceuticals
Biocon Limited
Torrent Pharma
Lupin Limited
Cadila Healthcare Limited
Aurobindo Pharma Limited
Intas Pharmaceuticals Limited
Glenmark Pharma Limited
Innovexia Life Sciences Pvt. Ltd.
Biophar Lifesciences Pvt. Ltd.
Mankind Pharma Limited
Piramal Enterprises Limited
Laurus Labs Ltd.
Abbott India Ltd.
Alkem Laboratories
Alembic Pharmaceuticals
Which is the No. 1 pharma company in India?
Based on revenue, Sun Pharmaceutical Industries Ltd. is the largest pharma company in India.
Who is the owner of Sun Pharma?
Dilip Shanghvi is the owner of Sun Pharmaceutical IndustriesLtd.
What are the pharma companies in Ahmedabad?
There are numerous pharma companies in Ahmedabad. Some of the major pharmaceutical companies are:
Torrent Pharmaceuticals
Zydus Cadila
Unison Pharmaceuticals Private Limited
Dishman Pharmaceuticals
Nabros Pharma Private Limited
Acron Pharmaceuticals
Nabros Pharma
What is the turnover of pharmaceutical companies in India?
The Indian pharmaceutical market (IPM) grew 6.8% to touch a turnover of Rs 1.93 trillion in the year 2023.
Company Profile is an initiative by StartupTalky to publish verified information on different startups and organizations.
To talk about pharma and medicines in today’s times, the industry is considered one of the most booming industries. These industries have offered a prevalence of contributions to the world of medicine. Medicines and drug usage has been there since immemorial, but the process of manufacturing has changed drastically.
These industries have a lengthy process and go through various stages such as design, formulation, fabrication, withdrawal, dispensation, distillation, and a lot of other things needed for the production of chemical substances.
Dr. Reddy’sLaboratories is dedicated to offering innovative, cost-effective medications for healthier living in the most integrated manner possible. It offers a variety of goods and services, such as APIs, specialised pharmaceutical services, generics, biosimilars, and unique formulations, through its three businesses, Pharmaceutical Services and Active Ingredients, Global Generics, and Proprietary Products.
Let’s dig more into Dr. Reddy Laboratories’ founders, business model, revenue, acquisitions, growth, and more in this article.
This pharma manufacturing company was founded in 1984 by Dr. Kallam Anji Reddy. The company initially started as a supplier for Indian drug manufacturers but shortly diversified its operations to export to other less-regulated markets. The company took advantage to get approval from other drug licensing companies like the U.S Food and Drug Administration (FDA), which resulted in huge profits that led to their formulations and setting up bulk drug manufacturing factories in advanced places.
Dr. Reddy’s main therapeutic interventions are in the areas of dermatology, cancer, diabetology, gastroenterology, oncology, and pain management. It has markets all over the world like in the USA, India, Russia & CIS countries, and Europe. The company has 21 manufacturing facilities spread over 66 countries.
India is one of the top 10 exporters of pharmaceuticals. It supplies 50% of vaccines in the global market, 40% of generic demand in the US, and 25% of all medicine in the UK.
As per a Pharmaceuticals industry report, India’s domestic pharmaceutical market was at $42 billion in 2021. It is predicted to reach $65 billion by 2024, and $120-130 billion by 2030.
Dr. Reddy’s Laboratories is known for manufacturing and marketing a wide range of pharmaceuticals in India and overseas
Dr. Reddy’s Laboratories – Founder
Dr. Kallam Anji Reddy is the founder of Dr. Reddy’s Laboratories.
Dr. Kallam Anji Reddy – Founder of Dr. Reddy’s Laboratories
Dr. Kallam Anji Reddy
Dr. K Anji Reddy was born in 1941 to a modest but prosperous farming family in the Andhra Pradesh hamlet of Tadepalli. His inspiration goes to his father as he grew up watching him make herbal pills and distributed them without charging any penny to the needy ones.
Dr. Anji Reddy completed his schooling at Anapothana Zilla Parishath High School Nutakki. He got his degree in B.Sc. (Tech) from the University Department of Chemical Technology, Mumbai. Soon after graduation, he got his PhD in Chemical Engineering from the National Chemical Laboratory, Pune. After that, he spent six years working for the government-owned Indian Drugs and Pharmaceuticals Ltd (IDPL). This exposure to working at the IDPL fueled his desire to start his own business.
Dr. Kallam Anji Reddy quotes, “It was a dream. It was not a plan on the drawing board, no. But it was a dream.”
For his contributions to the Indian pharmaceutical industry, the Indian Government honoured him with the Padma Shri in 2001 and the Padma Bhushan in 2011. He was also a representative on the Trade and Industry Council for the Indian Prime Minister.
Dr. Kallam Anji Reddy suffered from cancer and lost the battle on 15 March 2013. He died at the Apollo Hospital, Hyderabad. At present, the company is run by his son, Satish Reddy and son-in-law, G.V. Prasad.
Dr. Reddy’s Laboratories – Startup Story and Growth
Soon after the construction of its manufacturing plant at Bollaram, the company commenced its business in 1985. In one year, Dr. Reddy’s Laboratories got listed on the Bombay Stock Exchange and entered the international market during this year with the export of the API Methyldopa.
The company started its first manufacturing of Omeprazole in 1991, which is considered to be the best product worldwide soon after, they entered the Russian market, their first-ever international exposure.
In the late 1990s, Dr. Reddy’s Laboratories US generics market established its offices in New Jersey. Besides their international establishment, the company started manufacturing Biologics to give Indian consumers a taste of high–cost medicines at reasonable prices.
The company introduced the first generic medicine, “Ibuprofen” under its brand in the US in 2008 after experiencing significant growth in the Indian market.
In 2005, Dr. Reddy’s Lab developed India’s first drug for the treatment of diabetic foot ulcers.
To touching a revenue of $1 billion in the mid-2000s, the company made several drugs like antibody biosimilar monoclonal antibodies to treat certain autoimmune diseases to entering into Colombia with a portfolio of high-quality and affordable medicines for cancer patients in 2016, the company has come a long way.
In 2020, to combat Covid-19, Dr. Reddy’s Laboratories made several partnerships from all over the world to bring an innovative therapeutic approach to India. They came up with its first generic Otic suspension product in the U.S.
Last year, the company collaborated with Eli Lilly to export Baricitinib to India. They also collaborated with Merck to provide Molnupiravir to COVID-19 patients everywhere.
The vision of Dr. Reddy’s Laboratories is to live by seven core values, which they give a lot of importance to it. The seven values are:
Sustainability
Integrity and transparency
Safety
Quality
Collaboration and teamwork
Productivity
Respect for the individual
Dr. Reddy’s Laboratories – Name, Logo, and Tagline
Dr. Reddy’s Laboratories – Logo and Tagline
Since it was the dream of Dr. K Anji Reddy to create affordable medicine for every class of people, he started the company with his surname, Dr. Reddy’s Laboratories. The company works with the tagline, “Good Health Can’t Wait.”
Dr. Reddy’s Laboratories – Business Model
Dr. Reddy’s Laboratories’ business model is mostly about research and development, end-to-end production, and cutting-edge digital technology to fulfil its commitments to patients all around the world. Their business model is successful as they produce drugs in bulk size and have in-house R&D centres.
They do business by providing the following services:
India Branded Generics – By developing medicines for acute and chronic diseases, and establishing speciality care, institutional/hospital business, OTC, and eCommerce.
North America Generics – By having establishments in New Jersey, and Canada to offer their affordable healthcare to the world.
Emerging Markets Branded Generics – They have their services in Southeast Asian countries. The company provides medicines – the Association of Southeast Asian Nations (ASEAN), Africa, Australia, and New Zealand; CIS and Romania; China; Latin America and Russia.
Europe Generics – The company also offers its services to give access to affordable and innovative medicines in Europe as well. They have a presence in France, Germany, Italy, Netherlands, Spain, Ukraine, and United Kingdom.
Active Pharmaceutical Ingredients (APIs) – They manufacture bulk drugs or active pharmaceutical ingredients (APIs), which remain a cornerstone of the company.
Biologics – The company generates and markets a variety of immunology and oncology-related biosimilar medicines. This is the most integrated part of the company.
Aurigene Pharmaceutical Services – With scale-up and commercial manufacturing facilities in India, the UK, Mexico, and the US, Dr. Reddy’s Aurigene Pharmaceutical services provide discovery and development services at top-notch facilities in India.
Dr. Reddy’s Laboratories – Revenue
Dr. Reddy’s Laboratories Revenue from FY2015 to FY2022 (Revenue in billion INR)
The company mostly gets 45% earnings from North America Generics, then 18% from India, 19% from Russia, 12% from Europe, and 6% from the rest of the world.
The company has generated $74.9 billion from NAG, $16.6 billion from Europe, $45.7 billion from emerging markets, and $42 billion from India in FY22.
Dr. Reddy’s Laboratories recorded a revenue of $2.83 billion for FY22 which was an 8.94% increase from $2.59 billion in FY2021.
Dr. Reddy’s Laboratories launched Hyperinjection in US. The announcement of the company’s joint launch of Treprostinil injection in the US market with its subsidiaries came in April of 2023.
Gummies
CeleHealth Kidz Immuno Plus Gummies were introduced to the Indian market in July, 2023 by Dr. Reddy’s Laboratories. The product attempts to meet the dietary needs related to the increasing worries about kid immunity in India.
Celevida wellness
Dr. Reddy’s Laboratories Ltd. stated that Svaas Wellness Limited, a wholly-owned subsidiary, has launched “Celevida Wellness,” the company’s first direct-to-consumer (D2C) e-commerce website for diabetic patients on October, 26, 2023.
Dr. Reddy’s Laboratories – Funding
Company has raised $6 million in two funding rounds.
Date
Funding Round
Amount
Oct 3, 2022
Post-IPO Equity
–
Dec 1, 2001
Post-IPO Equity
$6M
Dr.Reddy’s Laboratories – Investments
Dr.Reddy’s Laboratories has Invested in one company to date:
Date
Funding Round
Company Name
Amount
Sep 30, 2005
Series A
Perlecan Pharma
$52.5M
Dr. Reddy’s Laboratories – Challenges Faced
The manufacturing business is the toughest business to operate especially in medicine and drugs. Dr. Reddy’s Laboratories have had faced challenges in its journey. There were a few controversies in which the company was caught up. The company had quality problems in its Mexico unit and a few fatal accidents.
Recently, the company announced a 76% year-over-year (YoY) decline in profit after tax (PAT) to Rs 88 crore in Q4FY22 due to pricing pressure in North America and Europe, decreased export benefits, and a rise in inventory reserves.
Dr.Reddy’s Laboratories – Partnership
Shanghai Junshi Biosciences Co., Ltd
Dr. Reddy’s Laboratories and Shanghai Junshi Biosciences Co., Ltd. has partnershiped on Augut, 5, 2023 to develop and market toripalimab, the anti-PD-1 monoclonal antibody, in South Africa, India, Latin America, and, upon Dr. Reddy’s election, Australia, New Zealand, and other nations.
Amazon Web Services
Amazon Web Services (AWS) has revealed that Dr Reddy’s Laboratories Limited (Dr Reddy’s), has partnershiped with AWS on July, 10, 2023 as its preferred cloud provider in order to facilitate the provision of new and reasonably priced medicines.
Theranica
Theranica, an Israeli digital therapeutics firm, has signed a strategic partnership and supply deal with Dr. Reddy’s Laboratories Ltd. for the exclusive marketing and distribution of its FDA-approved Nerivio in India.
Dr. Reddy’s Laboratories – Shareholders
The company has several shareholders. The following are the shareholders who hold 1% or more of the equity shares as of March 2022:
Name
Number of Shares
%
Dr. Reddy’s Holdings Limited
41,325,300
24.83
Life Insurance Corporation of India
8,769,499
5.27
SBI-ETF Sensex
4,245,926
2.55
Aditya Birla SunLife Trustee Private Limited
3,631,279
2.17
First Sentier Investors ICVC-Stewart Investors
3,500,511
2.1
ICICI Prudential Value Discovery Fund
3,224,070
1.92
Government of Singapore
3,004,517
1.81
ICICI Prudential Life Insurance Company Limited
2,743,177
1.64
NPS Trust and their associates
2,488,266
1.48
UTI-Mastershare Unit
1,991,477
1.19
HDFC Trustee Company
1,700,213
1.02
Government Pension Fund Global
1,677,349
1.01
Mirae Asset Tax Saver Fund and their associates
1,668,396
1
Dr. Reddy’s Laboratories – Mergers and Acquisitions
The company has made 6 acquisitions till now and is also open for M&A and is waiting for the right opportunity. The acquisitions are:
Dr. Reddy’s Laboratories – Awards and Achievements
The company has got several awards for its performance in the pharmaceutical industry. Below is the list of awards won by Dr. Reddy’s Laboratories:
Top Employers Institute – recognised as Top Employer in South Africa
Sustainability 4.0 Awards 2022 – Sustainable Corporate of the Year award
Dow Jones Sustainability Index 2021 – Among top 10 leaders globally; featured for 6th year in a row in the Emerging Markets category
Member of the Sustainability Yearbook 2022
Bloomberg Gender-Equality Index 2022 – the only Indian pharma company in the index
CII SCALE Award 2021 – for excellence in logistics and supply chain for the 7th consecutive year
CII Industrial Innovation Awards 2021
Global Generics & Biosimilars Awards 2021
United Nations Women’s Empowerment Principles Awards – 2nd runner-up in the Gender Inclusive Workplace category in Asia-Pacific
Indo-American Chamber of Commerce 2021
Economic Times – Futurescape 8th Sustainability Index Report 2021
Dr. Reddy’s Columbia – Great Place to Work in 2021
Dr. Reddy’s Laboratories – Future Plans
The company is aiming to be among the top 5 drug maker companies in the domestic market by planning mergers and acquisitions to up its game.
The co-chairman and managing director of Dr. Reddy’s Laboratories,GV Prasad said in an interview, “Getting into the top 5 is our aspiration. On an organic curve, you can’t reach there (top five). We are open for M&A but for the right price and buttressed by organic execution. We have to pull all the levers”.
FAQs
When was Dr. Reddy’s Laboratories founded?
Dr. Reddy’s Laboratories was founded in the year 1984 and is headquartered in Hyderabad.
Who is the founder of Dr. Reddy’s Laboratories?
Dr. Kallam Anji Reddy is the founder of Dr. Reddy’s Laboratories.
What was Dr. Reddy’s revenue in 2022?
Dr. Reddy’s Laboratories recorded revenue of 2.8 billion USD in FY2022.
What was Dr. Reddy’s Laboratories’ recent acquisition?
Dr. Reddy’s Laboratories’ most recently acquired Germany-based Nimbus Health GmbH. The company announced the agreement of acquisition in February 2022.
India started its vaccination programme for Covid-19 on 16 January 2021. The vaccination was first prioritized for frontline and healthcare workers. The Covishield vaccine and Covaxin have been approved by the government. There are many more companies working behind developing the vaccine in the country.
Serum Institute of India is an Indian Pharmaceuticals and Biotechnology company. It is the largest manufacturer of Vaccines around the globe. The company was founded in 1966 by Cyrus Poonawalla and is based in Pune, India. Adar Poonawalla is the Chairman, President, and CEO of the company.
Serum Institute of India has tied up with Astra Zeneca which is a pharmaceutical company. The company has released a vaccine called Covishield. They have also tied up with a U.S based rival Novavax.Inc.
The company has received funding from big organizations such as the Bill & Melinda Gates Foundation and Gavi Vaccine group. The funding is for delivering up to 200 million doses of both the vaccines for other low- and middle-income countries across the world and India.
In June 2020 Astra Zeneca had licensed the company to supply doses of its vaccines of up to 1 billion in numbers. It was concentrated on 60 low- and middle-income countries. Serum Institute of India is working on developing in-house vaccines and has partnered with Austria’s Themis and U.S. biotech firm Codagenix to potentially manufacture their COVID-19 vaccines.
Serum Institute of India has already made and stored more than 50 million doses of Covishield. The company aims to increase its production to 400 million doses by the by the mid of 2021.
Bharath Biotech
Bharath Biotech International Limited is an Indian company which deals with biotechnology. The company has its headquarters in Hyderabad, India. The company is involved in drug development, manufacture of vaccines, drug discovery, bio-therapeutics, healthcare products, and pharmaceuticals.
The company was founded in the year 1966 by Krishna Ella. Krishna M Ella is the Chairman and the MD of the company. The company is working together with a U.S based company FluGen and the University of Wisconsin-Madison in the development of a vaccine against Covid-19.
It has partnered with the state-run Indian Council of Medical research in developing a vaccine against Covid-19 called as COVAXIN. The Company is trying to reach an agreement with more than 10 countries in Southern America, Eastern Europe, and Asia to sell their vaccines. The vaccine has been provided to the citizens of India.
Biological E Limited is an Indian company which deals with Biopharmaceuticals. The company has its headquarters in Hyderabad, India. The company is involved in low-cost vaccine production in the country.
The company was founded in the year 1953 by Datla Venkata Krishnam Raju. Mahima Datla is the Managing Director of the company. The company had started its trials in November. It started its Phase I and Phase II trials.
The company had come into a partnership with Dynavax technologies and Baylor College of Medicine in Houston for the development of Covid-19 Vaccines.
Countries Where Coronavirus Vaccine will be produced
Cadila Healthcare Limited
Cadila Healthcare Ltd is an Indian Multinational Company which deals with pharmaceuticals. The company has its headquarters in Ahmedabad, Gujarat, India. The company is involved in the manufacturing of generic drugs. In the fortune India 500 list, the company was ranked 100th in 2020.
Cadila Healthcare Ltd was founded in the year 1952 by Ramanbhai Patel. Pankaj R Patel is the chairman of the company and the Managing Director of the company is Sharvil P Patel.
The company got permission to conduct human trials for its Covid-19 vaccine named ZyCOV-D in July 2020 by the Drugs Controller General of India, Government of India. Cadila Healthcare Ltd has said that it will be able to produce up to 100 million doses of vaccines in a year in the initial stages.
Dr. Reddy’s Laboratories is an Indian Multinational Company which deals with the manufacturing and marketing of pharmaceuticals in India and across the globe. The company has its headquarters in Hyderabad, India.
The company has over 60 active pharmaceutical ingredients (APIs) for drug manufacture, 190 medications, critical care, biotechnology products, and diagnostic kits. The company was founded in the year 1984 by Kallam Anji Reddy, who is the Chairman of the company and Erez Israeli is the CEO of the company.
The company entered into an agreement with Russia to conduct final trials of its vaccine Gam-COVID-Vac (Sputnik V) Vaccine in India. The company plans to distribute around 100 million doses in the Country.
The Russian Direct Investment Fund will be supplying the vaccines for distribution in India. The subsidiary company of Dr. Reddy’s Laboratories Ltd Hetero Biopharma has announced that they would produce 100 million doses of Sputnik V.
FAQ
Which Covid vaccine is used in India?
Covishield vaccine, manufactured by Serum Institute of India, and Bharat Biotech’s Covaxin are being used for the vaccination programme.
How many doses is AstraZeneca vaccine?
The AstraZeneca COVID-19 vaccine is given on a two-dose schedule.
What is the official name of the coronavirus disease?
On 11 February 2020ICTV announced “severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)” as the name of the new virus.
Conclusion
The top companies are in the run for producing the Covid-19 Vaccines in India. There are already some vaccines being provided for the people in the country. 0.43% of the Indian population has already been vaccinated in the Country. Around 32.9 million doses of the vaccines have been provided in the country and 5.87 million have been fully vaccinated.
Vivek Dev Jacob
